Morgan Stanley’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.73M | Sell |
509,533
-126,186
| -20% | -$1.42M | ﹤0.01% | 3949 |
|
|
2025
Q1 | $3.62M | Buy |
635,719
+70,447
| +12% | +$402K | ﹤0.01% | 4196 |
|
|
2024
Q4 | $5.55M | Buy |
565,272
+293,474
| +108% | +$2.88M | ﹤0.01% | 3906 |
|
|
2024
Q3 | $2.22M | Buy |
271,798
+121,823
| +81% | +$993K | ﹤0.01% | 4574 |
|
|
2024
Q2 | $2.01M | Sell |
149,975
-1,076,807
| -88% | -$14.4M | ﹤0.01% | 4565 |
|
|
2024
Q1 | $56.9M | Sell |
1,226,782
-1,221,359
| -50% | -$56.7M | ﹤0.01% | 1633 |
|
|
2023
Q4 | $165M | Buy |
2,448,141
+1,203,955
| +97% | +$81.4M | 0.01% | 1297 |
|
|
2023
Q3 | $90.1M | Buy |
1,244,186
+42,651
| +4% | +$3.09M | 0.01% | 1126 |
|
|
2023
Q2 | $89.4M | Sell |
1,201,535
-274,475
| -19% | -$20.4M | 0.01% | 1161 |
|
|
2023
Q1 | $78.5M | Buy |
1,476,010
+198,904
| +16% | +$10.6M | 0.01% | 1208 |
|
|
2022
Q4 | $86.3M | Sell |
1,277,106
-78,994
| -6% | -$5.34M | 0.01% | 1120 |
|
|
2022
Q3 | $169M | Buy |
1,356,100
+375,774
| +38% | +$46.9M | 0.02% | 639 |
|
|
2022
Q2 | $93.3M | Buy |
980,326
+355,839
| +57% | +$33.9M | 0.01% | 963 |
|
|
2022
Q1 | $101M | Buy |
624,487
+261,113
| +72% | +$42.1M | 0.01% | 863 |
|
|
2021
Q4 | $121M | Buy |
363,374
+81,513
| +29% | +$27.1M | 0.01% | 781 |
|
|
2021
Q3 | $131M | Buy |
+281,861
| New | +$131M | 0.02% | 699 |
|